|
1
|
Cayssials E, Torregrosa-Diaz J, Leleu X, Guilhot F, Chomel JC. Reply to Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study. Cancer 2020; 127:976-978. [PMID: 33095912 DOI: 10.1002/cncr.33281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Accepted: 09/16/2020] [Indexed: 11/09/2022]
Affiliation(s)
- Emilie Cayssials
- Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, France.,INSERM CIC 1402, CHU Poitiers, France.,INSERM 1082, Poitiers, France
| | - Jose Torregrosa-Diaz
- Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, France.,INSERM CIC 1402, CHU Poitiers, France
| | - Xavier Leleu
- Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, France.,INSERM CIC 1402, CHU Poitiers, France
| | | | | |
Collapse
|
|
2
|
Detection of Two Genotoxic Impurities in Drug Substance and Preparation of Imatinib Mesylate by LC–MS/MS. Chromatographia 2020. [DOI: 10.1007/s10337-020-03903-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|